Occurrence and significance of autoantibodies in the course of interferon treatment of chronic hepatitis C;Vorkommen und Bedeutung von Autoantikorpern im Rahmen der Interferontherapie der chronischen Hepatitis C

Deutsche Medizinische Wochenschrift

Volumn 121, Issue 39, 1996, Pages 1179-1183

  Heller, J ^a,b   Musiolik, J ^a,b   Homrighausen, A ^a,b   Sauerbruch, T ^a,b   Spengler, U ^a,b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; THYROID ANTIBODY; THYROGLOBULIN;

ADULT; ARTICLE; AUTOIMMUNITY; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG EFFECT; ETIOLOGY; FEMALE; HASHIMOTO DISEASE; HEPATITIS C; HUMAN; MALE; RISK ASSESSMENT; SIDE EFFECT; THYROID FUNCTION; AGED; AUTOIMMUNE THYROIDITIS; BIOSYNTHESIS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; THYROID GLAND;

ADULT; AGED; AUTOANTIBODIES; FEMALE; HEPATITIS C; HEPATITIS, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; THYROGLOBULIN; THYROID GLAND; THYROIDITIS, AUTOIMMUNE;

EID: 0030603912     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043123     Document Type: Article

References (22)

1. Abuaf, N., F. Lunel, F. Giral, P. Borotto, S. Laperche, R. Poupon, P. Opolon, J.-M. Huraux, J. C. Homberg: Non-organ specific autoantibodies associated with chronic C virus hepatitis. J. Hepatol. 18 (1993), 359-364.
2. Barreca, T., A. Picciotto, R. Franceschini, G. Varagona, G. Corsini, A. Cataldi, E. Molinari, A. Garibaldi, E. Rolandi: Long term therapy with recombinant interferon alpha 2b in patients with chronic hepatitis C. J. biol. Regulat. homeostat. Agents 7 (1993), 58-62.
3. Baudin, E., P. Marcellin, M. Pouteau, N. Colas-Linhart, J.-P. Le Floch, C. Lemmonier, J.-P. Benhamou, B. Bok: Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin. Endocrinol. 39 (1993), 657-661.
4. Boadas, J., J. Rodriguez-Espinosa, J. Enriquez, F. Miralles, F. J. Martinez-Cerezo, P. Gonzalez, P. Madoz, F. Vilardell: Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection. J. Hepatol. 22 (1995), 611-615.
5. Chung, Y. H., Y. Kee Shong: Development of thyroid autoimmunity after administration of recombinant human interferon-α2b for chronic viral hepatitis. Amer. J. Gastroenterol. 88 (1993), 244-247.
6. Conlon, K. C., W. J. Urba, J. W. Smith, R. G. Steis, D. L. Longo, J. W. Clark: Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer 65 (1990), 2237.
7. Fentinman, I. S., F. R. Balkwill, B. S. Thomas: An autoimmune aetiology of hypothyreoidism following interferon therapy for breast cancer. Europ. J. Cancer clin. Oncol. 24 (1988), 1299-1301.
8. Imagawa, A., N. Itoh, T. Hanafusa, Y. Oda, M. Waguri, J. I. Miyagawa, N. Kono, M. Kuwajima, Y. Matsuzawa: Autoimmune endocrine disease induced by recombinant IFN-α therapy for chronic active type C Hepatitis. J. clin. Endocrinol. Metabol. 80 (1995), 922-926.
9. Lenzi, M., G. Ballardini, M. Fusconi, F. Cassani, L. Selleri, D. Volta, D. Zauli, F. B. Bianchi: Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 335 (1990), 258-259.
10. Lisker-Melman, M., A. M. Di Bisceglie, S. J. Usala, B. Weintraub, L. M. Murray, J. H. Hoofnagle: Development of thyroid disease during therapy of chronic viral hepatitis with interferon alpha. Gastroenterol. 102 (1992), 2155-2160.
11. Manns, P. M., K. J. Griffin, K. F. Sullivan, F. F. Johnson: LKM-1 autoantibodies recognize a short linear sequence in P450 IID6, a cytochrom P-450 monooxydase. J. clin. Invest. 88 (1991), 1370-1378.
12. Marcellin, P., V. Descamps, M. Martinot-Peignoux, D. Larzul, L. Xu, N. Boyer, B.-N. Pham, B. Crickx, L. Guillevin, S. Belaich, S. Erlinger, J.-P. Benhamou: Cryoglobulinemia with vasculitis associated with hepatitis C virus infection. Gastroenterology 104 (1993), 272-277.
13. Mayet, W.-J., G. Hess, G. Gerken, S. Rossol, R. Voth, M. Manns, K.-H. Meyer zum Büschenfelde: Treatment of chronic type B hepatitis with recombinant α-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology 10 (1989), 24.
14. Muratori, L., M. Lenzi, M. Cataleta, F. Giostra, Cassani Fabio, G. Ballardini, D. Zauli, F. B. Bianchi: Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C. J. Hepatol. 21 (1994), 199-202.
15. Pawlotsky, J. M., L. Deforges, S. Bretagne, C. Andre, J. M. Metreau, V. Thiers, E. S. Zafrani, M. Goossens, J. Duval, J. P. Mavier, D. Dhumeaux: Hepatitis C virus infection can mimic type 1 (antinuclear antibody positive) autoimmune chronic active hepatitis. Gut (1993), suppl. S66-S68.
16. Pawlotsky, J.-M., M. B. Yahia, C. Andre, M.-C. Voisin, L. Intrator, F. Roudot-Thoraval, I. Deforges, C. Duvoux, E.-S. Zafrani, J. Duval, D. Dhumeaux: Immunological disorders in C virus active hepatitis: A prospective case-control study. Hepatology 19 (1994), 841-848.
17. Pawlotsky, J. M., F. Roudt-Thoraval, P. Simmonds, J. Mellor, M. Ben Yahia, C. Andre, M. C. Voisin, L. Intrator, E. S. Zafrani, J. Duval, D. Dhumeaux: Extrahepatic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann. intern. Med. 122 (1995), 169.
18. Preziati, D., L. La Rosa, G. Covini, R. Marcelli, S. Rescalli, L. Persani, E. Del Ninno, P. L. Meroni, M. Colombo, P. Beck-Peccoz: Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. Europ. J. Endocrinol. 132 (1995), 587-593.
19. Ronblom, L. E., G. V. Alm, K. E. Oberg: Autoimmunity after alpha interferon therapy for malignant carcinoid tumors. Ann. intern. Med. 3 (1991), 178-183.
20. Scalzo, S., A. Genaro, G. Boccoli, R. Masciulli, G. Gianella, G. Savo, P. Marolla, P. Carlini, G. Massimini, E. E. Holdener, U. Testa, F. Calabresi, C. Peschle: Primary hypothyroidism associated with interleukin-2 and interferon-α-2 therapy of melanoma and renal carcinoma. Europ. J. Cancer 26 (1990), 1152-1156.
21. Tran, A., J.-F. Quaranta, S. Benzaken, V. Thiers, H. T. Chuan, P. Hastier, D. Regnier, G. Dreyfus, C. Pradier, J. L. Sadoul, X. Hebuterne, P. Rampal: High Prevalence of thyroid autoantibodies in a prospective series of patients with hepatitis C before Interferon therapy. Hepatology 18 (1993), 253-257.
22. Watanabe, U., E. Hasimoto, T. Hisamitsu, H. Obata, N. Hayashi. The risk factor of thyroid disease during Interferon-α therapy for chronic hepatitis C Amer. J. Gastroenterol. 3 (1994), 399-403.